Xenon Historical Income Statement
| XENE Stock | USD 38.52 1.10 2.78% |
Historical analysis of Xenon Pharmaceuticals income statement accounts such as Depreciation And Amortization of 4.3 M, Interest Expense of 6.7 M, Selling General Administrative of 56.2 M or Total Revenue of 0.0 can show how well Xenon Pharmaceuticals performed in making a profits. Evaluating Xenon Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Xenon Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Xenon Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Xenon Pharmaceuticals is a good buy for the upcoming year.
Xenon |
About Xenon Income Statement Analysis
Xenon Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Xenon Pharmaceuticals shareholders. The income statement also shows Xenon investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Xenon Pharmaceuticals Income Statement Chart
Add Fundamental
Total Revenue
Total revenue comprises all receipts Xenon Pharmaceuticals generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Xenon Pharmaceuticals. It is also known as Xenon Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Operating Income
Operating Income is the amount of profit realized from Xenon Pharmaceuticals operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Xenon Pharmaceuticals is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Most accounts from Xenon Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Xenon Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.At present, Xenon Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 56.2 M, whereas Gross Profit is projected to grow to (143.2 M).
Xenon Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Xenon Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Xenon Pharmaceuticals income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Depreciation And Amortization | 644K | 906K | 1.6M | 3.5M | 4.1M | 4.3M | |
| Interest Expense | 1.4M | 484K | 1.0M | 5.5M | 6.3M | 6.7M | |
| Selling General Administrative | 12.9M | 22.0M | 32.8M | 46.5M | 53.5M | 56.2M | |
| Gross Profit | 32.2M | 18.4M | 9.4M | (167.5M) | (150.8M) | (143.2M) | |
| Other Operating Expenses | 63.5M | 97.4M | 138.6M | 214.1M | 246.2M | 258.5M | |
| Operating Income | (31.3M) | (79.0M) | (129.1M) | (214.1M) | (192.6M) | (183.0M) | |
| Ebit | (31.3M) | (79.0M) | (129.1M) | (214.1M) | (192.6M) | (183.0M) | |
| Research Development | 50.5M | 75.5M | 105.8M | 167.5M | 192.6M | 202.3M | |
| Ebitda | (30.7M) | (78.1M) | (127.5M) | (210.5M) | (189.5M) | (180.0M) | |
| Total Operating Expenses | 63.5M | 97.4M | 138.6M | 46.5M | 53.5M | 49.4M | |
| Income Before Tax | (29.1M) | (78.9M) | (125.3M) | (182.7M) | (164.4M) | (156.2M) | |
| Total Other Income Expense Net | 2.2M | 105K | 3.9M | 31.4M | 36.1M | 37.9M | |
| Net Income | (28.8M) | (78.9M) | (125.4M) | (182.4M) | (164.2M) | (155.9M) | |
| Income Tax Expense | (257K) | (6K) | 118K | (292K) | (335.8K) | (319.0K) | |
| Cost Of Revenue | 50.5M | 75.5M | 105.8M | 167.5M | 192.6M | 202.3M | |
| Net Income From Continuing Ops | (28.8M) | (78.9M) | (125.4M) | (175.0M) | (157.5M) | (149.7M) | |
| Net Income Applicable To Common Shares | (40.0M) | (28.0M) | (77.1M) | (124.9M) | (112.4M) | (106.8M) | |
| Non Operating Income Net Other | 2.6M | 2.7M | 105K | 3.9M | 4.5M | 4.7M | |
| Interest Income | 2.3M | 466K | 8.7M | 23.4M | 26.9M | 28.2M | |
| Net Interest Income | 1.8M | 466K | 8.7M | 23.4M | 26.9M | 28.2M | |
| Reconciled Depreciation | 644K | 906K | 1.6M | 3.2M | 3.7M | 3.9M | |
| Tax Provision | (257K) | (6K) | 118K | 1.1M | 1.2M | 1.3M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Xenon Pharmaceuticals. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Xenon Stock refer to our How to Trade Xenon Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Xenon Pharmaceuticals. If investors know Xenon will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Xenon Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Xenon Pharmaceuticals is measured differently than its book value, which is the value of Xenon that is recorded on the company's balance sheet. Investors also form their own opinion of Xenon Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Xenon Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Xenon Pharmaceuticals' market value can be influenced by many factors that don't directly affect Xenon Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Xenon Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Xenon Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Xenon Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.